Anti-MAG antibodies in 202 patients: Clinicopathological and therapeutic features
Revue Neurologique(2018)
Abstract
The purpose of this study was to assess the clinicopathological and therapeutic features of patients with low (≥1000–<10 000 Bühlmann® Titre Units) (BTU), medium (10 000–70 000) or high (≥70 000) anti-Myelin-Associated Glycoprotein (MAG) antibody titres.
MoreTranslated text
Key words
Rituximab,Monoclonal IgM gammopathy,Myelin-associated glycoprotein
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined